Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Multiple Myeloma 38Lymphoma, Non-Hodgkin 14Hodgkin Disease 13Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Myelodysplastic Syndromes 11Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Neoplasms, Plasma Cell 10Leukemia, Myeloid, Acute 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Hematologic Neoplasms 6Primary Myelofibrosis 4Recurrence 3Myeloproliferative Disorders 3Lymphoma, Follicular 3Leukemia, Plasma Cell 3Leukemia, Myelomonocytic, Chronic 3Graft vs Host Disease 3Anemia, Aplastic 3Polycythemia Vera 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Hematologic Diseases 2Wilms Tumor 1Thrombocytopenia 1Thrombocythemia, Essential 1Testicular Neoplasms 1Smoldering Multiple Myeloma 1

Interventions

romiplostim 2fludarabine 1eltrombopag 1Surveys and Questionnaires 1Stem Cell Transplantation 1Ritonavir 1Quality of Life 1Metformin 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × Stem Cell Transplantation × Plasma cell × Clear all
NCT03303950 2022-05-05

Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

University of Utah

Phase 2 Terminated
6 enrolled 17 charts
Classical hematologyMyeloidPlasma cell

Anemia, Multiple Myeloma, Thrombocytopenia, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡